Literature DB >> 18472876

Effect of resident physician education regarding selective chemoprophylaxis for the prevention of early onset group B streptococcal sepsis: an outcome study.

J S Greenspoon1, D J Rosen, A P Sumen.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the effect of a voluntary protocol for selective intrapartum chemoprophylaxis on the incidence of early onset group B streptococcal sepsis (GBS EOS).
METHODS: Cases of GBS EOS were defined as a positive GBS culture from a normally sterile fluid obtained during the first 7 days of life. All cases of GBS EOS at an urban, university-affiliated community hospital were reviewed during 2 time periods. The 2-year period before instituting a resident education program to promote selective chemoprophylaxis (1988-89) was retrospectively reviewed; the 2-year period after the education program was introduced (1990-91) was prospectively recorded. The outcome measure was the incidence of GBS EOS.
RESULTS: The rate of GBS EOS was 7/14,335 deliveries (0.05%) before and 9/13,999 (0.064%) after the introduction of the education program (observed difference between proportions 0.016%, 95% confidence interval [CI] for the difference between the proportions -0.071% to 0.04%, P = not significant [NS]). The rate of GBS EOS in preterm infants was 5/1,331 (0.376%) before and 3/1,297 (0.23%) afterward (observed difference between proportions 0.14%, 95% CI -0.28% to 0.56%, P = NS). The incidence of GBS EOS did not decrease during the latter period due to failure of antepartum cultures to predict intrapartum GBS colonization (2 cases); non-compliance with voluntary recommendations to administer chemoprophylaxis (2 cases); failure of chemoprophylaxis or therapy for intraamniotic infection to prevent neonatal infection (3 cases); and occurrence of GBS EOS in infants without risk factors (2 cases).
CONCLUSIONS: An education program for resident physicians regarding chemoprophylaxis for GBS EOS did not significantly reduce the absolute incidence of disease. Alternative strategies are needed that redress the causes of failure inherent in the current guidelines. Some cases of GBS EOS are not preventable because the parturient does not have risk factors that indicate chemoprophylaxis.

Entities:  

Year:  1994        PMID: 18472876      PMCID: PMC2366147          DOI: 10.1155/S1064744994000116

Source DB:  PubMed          Journal:  Infect Dis Obstet Gynecol        ISSN: 1064-7449


  16 in total

1.  Consensus: perinatal prophylaxis for group B streptococcal infection.

Authors:  R S Gibbs; R T Hall; M D Yow; G H McCracken; J D Nelson
Journal:  Pediatr Infect Dis J       Date:  1992-03       Impact factor: 2.129

2.  An obstetric approach to the prevention of early-onset group B beta-hemolytic streptococcal sepsis.

Authors:  H Minkoff; P Mead
Journal:  Am J Obstet Gynecol       Date:  1986-05       Impact factor: 8.661

3.  When to treat intra-amniotic infection.

Authors:  P B Mead
Journal:  Obstet Gynecol       Date:  1988-12       Impact factor: 7.661

4.  Cost-effectiveness of intrapartum screening and treatment for maternal group B streptococci colonization.

Authors:  D M Strickland; E R Yeomans; G D Hankins
Journal:  Am J Obstet Gynecol       Date:  1990-07       Impact factor: 8.661

5.  Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale.

Authors:  K M Boyer; C A Gadzala; L I Burd; D E Fisher; J B Paton; S P Gotoff
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

6.  The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group.

Authors:  J A Regan; M A Klebanoff; R P Nugent
Journal:  Obstet Gynecol       Date:  1991-04       Impact factor: 7.661

7.  Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis.

Authors:  K M Boyer; S P Gotoff
Journal:  N Engl J Med       Date:  1986-06-26       Impact factor: 91.245

8.  Epidemiology of group B Streptococcus: longitudinal observations during pregnancy.

Authors:  B F Anthony; D M Okada; C J Hobel
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

Review 9.  Group B streptococcus: the effectiveness of screening and chemoprophylaxis.

Authors:  J S Greenspoon; J G Wilcox; T H Kirschbaum
Journal:  Obstet Gynecol Surv       Date:  1991-08       Impact factor: 2.347

10.  Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures.

Authors:  K M Boyer; C A Gadzala; P D Kelly; L I Burd; S P Gotoff
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.